Resultados da busca - Nicholas Butowski

Refinar Resultados
  1. 1
    Therapeutic and Supportive Effects of Cannabinoids in Patients with Brain Tumors (CBD Oil and Cannabis)

    Therapeutic and Supportive Effects of Cannabinoids in Patients with Brain Tumors (CBD Oil and Cannabis) por Eduardo Rodriguez Almaraz, Nicholas Butowski

    Publicado em 2023
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  2. 2
    Recent Advances in Therapy for Glioblastoma

    Recent Advances in Therapy for Glioblastoma por Jennifer Clarke, Nicholas Butowski, Susan M. Chang

    Publicado em 2010
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  3. 3
    Treatment options for recurrent high-grade gliomas

    Treatment options for recurrent high-grade gliomas por Harjus Birk, Seunggu J. Han, Nicholas Butowski

    Publicado em 2016
    Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  4. 4
    A systematic review of high impact CpG sites and regions for MGMT methylation in glioblastoma [A systematic review of MGMT methylation in GBM]

    A systematic review of high impact CpG sites and regions for MGMT methylation in glioblastoma [A systematic review of MGMT methylation in GBM] por David R. Gibson, Anh Huan Vo, Hannah Lambing, Prithanjan Bhattacharya, Peggy Tahir, Farid Chehab, Nicholas Butowski

    Publicado em 2024
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  5. 5
    Conditional Probability of Survival in Patients With Newly Diagnosed Glioblastoma

    Conditional Probability of Survival in Patients With Newly Diagnosed Glioblastoma por Mei‐Yin C. Polley, Kathleen R. Lamborn, Susan M. Chang, Nicholas Butowski, Jennifer Clarke, Michael D. Prados

    Publicado em 2011
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  6. 6
    Mouse models of glioblastoma for the evaluation of novel therapeutic strategies

    Mouse models of glioblastoma for the evaluation of novel therapeutic strategies por Alexander F. Haddad, Jacob S. Young, Dominic Amara, Mitchel S. Berger, David R. Raleigh, Manish K. Aghi, Nicholas Butowski

    Publicado em 2021
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  7. 7
    MRI Features and <i>IDH</i> Mutational Status of Grade II Diffuse Gliomas: Impact on Diagnosis and Prognosis

    MRI Features and <i>IDH</i> Mutational Status of Grade II Diffuse Gliomas: Impact on Diagnosis and Prognosis por Javier Villanueva-Meyer, Matthew D. Wood, Byung Se Choi, Marc C. Mabray, Nicholas Butowski, Tarık Tihan, Soonmee Cha

    Publicado em 2017
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  8. 8
    The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma

    The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma por Seunggu J. Han, Caleb Rutledge, Annette M. Molinaro, Susan M. Chang, Jennifer Clarke, Michael D. Prados, Jennie Taylor, Mitchel S. Berger, Nicholas Butowski

    Publicado em 2015
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  9. 9
    Characterization and Management of Dermatologic Adverse Events With the NovoTTF-100A System, a Novel Anti-mitotic Electric Field Device for the Treatment of Recurrent Glioblastoma

    Characterization and Management of Dermatologic Adverse Events With the NovoTTF-100A System, a Novel Anti-mitotic Electric Field Device for the Treatment of Recurrent Glioblastoma por Mario E. Lacouture, Mary E. Davis, Grace Elzinga, Nicholas Butowski, David Tran, John L. Villano, Lucianna DiMeglio, Angela M. Davies, Eric T. Wong

    Publicado em 2014
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  10. 10
    Phase II trial of 7 days on/7 days off temozolmide for recurrent high-grade glioma

    Phase II trial of 7 days on/7 days off temozolmide for recurrent high-grade glioma por Seunggu J. Han, John D. Rolston, Annette M. Molinaro, Jennifer Clarke, Michael D. Prados, Shannon Chang, Mitchel S. Berger, Annissa DeSilva, Nicholas Butowski

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  11. 11
    A single-institution phase II trial of radiation, temozolomide, erlotinib, and bevacizumab for initial treatment of glioblastoma

    A single-institution phase II trial of radiation, temozolomide, erlotinib, and bevacizumab for initial treatment of glioblastoma por Jennifer Clarke, Annette M. Molinaro, Joanna J. Phillips, Nicholas Butowski, Shannon Chang, Arie Perry, J Costello, Annissa DeSilva, Jane Rabbitt, Michael D. Prados

    Publicado em 2014
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  12. 12
    Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant glioma

    Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant glioma por Edward Pan, Jeffrey G. Supko, Thomas Kaley, Nicholas Butowski, Timothy F. Cloughesy, Jinkyu Jung, Serena Desideri, Stuart A. Grossman, Xiaobu Ye, Deric M. Park

    Publicado em 2016
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  13. 13
    Quality of life in low-grade glioma patients receiving temozolomide

    Quality of life in low-grade glioma patients receiving temozolomide por Raymond Liu, Karla Solheim, Mei‐Yin C. Polley, Kathleen R. Lamborn, Margaretta Page, Anne Fedoroff, Jane Rabbitt, Nicholas Butowski, Michael D. Prados, Susan M. Chang

    Publicado em 2008
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  14. 14
    Nivolumab plus radiotherapy with or without temozolomide in newly diagnosed glioblastoma: Results from exploratory phase I cohorts of CheckMate 143

    Nivolumab plus radiotherapy with or without temozolomide in newly diagnosed glioblastoma: Results from exploratory phase I cohorts of CheckMate 143 por Antonio Omuro, David A. Reardon, John H. Sampson, Joachim M. Baehring, Solmaz Sahebjam, Timothy F. Cloughesy, Alexandros-Georgios Chalamandaris, Von Potter, Nicholas Butowski, Michael Lim

    Publicado em 2022
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  15. 15
    Clinical Practice Experience With NovoTTF-100A™ System for Glioblastoma: The Patient Registry Dataset (PRiDe)

    Clinical Practice Experience With NovoTTF-100A™ System for Glioblastoma: The Patient Registry Dataset (PRiDe) por Maciej M. Mrugała, Herbert H. Engelhard, David Tran, Yvonne Kew, Robert Cavaliere, John L. Villano, Daniela A. Bota, Jeremy Rudnick, Ashley Sumrall, Jay‐Jiguang Zhu, Nicholas Butowski

    Publicado em 2014
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  16. 16
    A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05)

    A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05) por Nicholas Butowski, Susan M. Chang, Larry Junck, Lisa M. DeAngelis, Lauren E. Abrey, Karen Fink, Tim Cloughesy, Kathleen R. Lamborn, Andres Μ. Salazar, Michael D. Prados

    Publicado em 2008
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  17. 17
    A phase I study of convection-enhanced delivery (CED) of liposomal-irinotecan using real-time magnetic resonance imaging in patients with recurrent high-grade glioma

    A phase I study of convection-enhanced delivery (CED) of liposomal-irinotecan using real-time magnetic resonance imaging in patients with recurrent high-grade glioma por Kazim Narsinh, Karishma Kumar, Krystof Bankiewicz, Alastair J. Martin, Mitchel S. Berger, Jennifer Clarke, Jennie Taylor, Nancy Ann Oberheim Bush, Annette M. Molinaro, Manish K. Aghi, Nicholas Butowski

    Publicado em 2025
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  18. 18
    Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma1

    Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma1 por Michael D. Prados, Kathleen R. Lamborn, Susan M. Chang, Eric Burton, Nicholas Butowski, Mary Malec, A. Kapadia, Jane Rabbitt, Margaretta S. Page, Ann Fedoroff, Dong Xie, Sean K. Kelley

    Publicado em 2006
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  19. 19
    Integration of preoperative anatomic and metabolic physiologic imaging of newly diagnosed glioma

    Integration of preoperative anatomic and metabolic physiologic imaging of newly diagnosed glioma por Susan M. Chang, Sarah J. Nelson, Scott R. VandenBerg, Soonmee Cha, Michael D. Prados, Nicholas Butowski, Michael McDermott, Andrew T. Parsa, Manish K. Aghi, Jennifer Clarke, Mitchel S. Berger

    Publicado em 2009
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  20. 20
    Phase-2 trial of palbociclib in adult patients with recurrent RB1-positive glioblastoma

    Phase-2 trial of palbociclib in adult patients with recurrent RB1-positive glioblastoma por Jennie Taylor, Mili Parikh, Joanna J. Phillips, C. David James, Annette M. Molinaro, Nicholas Butowski, Jennifer Clarke, Nancy Ann Oberheim-Bush, Susan M. Chang, Mitchel S. Berger, Michael D. Prados

    Publicado em 2018
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:

Ferramentas de busca: